Abstract Details
|
PRESENTER |
No disclosure on file |
| Sunil G. Nair, MD (UW Health- Neurology Clinic) | No disclosure on file |
| Kimberly A. Cole, PhD, NP | Ms. Cole has nothing to disclose. |
| Anum H. Riaz, MD | Dr. Riaz has nothing to disclose. |
| Imran I. Ali, MD, FAAN (University of Toledo COM) | Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. |
| Thomas A. Berger, MD (Dept. of Neurology, Medical University of Vienna) | Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB). |